Shares of CVS Health Corporation (NYSE:CVS) have received a consensus rating of “Buy” from the twenty-five ratings firms that are currently covering the stock. Five equities research analysts have rated the stock with a hold recommendation, eighteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $111.75.

A number of research firms recently commented on CVS. Deutsche Bank AG upped their price objective on CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a report on Wednesday, June 22nd. Argus reiterated a “buy” rating and issued a $120.00 price objective on shares of CVS Health Corporation in a report on Thursday, August 4th. Leerink Swann restated a “buy” rating on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Zacks Investment Research upgraded CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. Finally, Mizuho increased their price target on CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a report on Thursday, August 4th.

A number of institutional investors have recently added to or reduced their stakes in the stock. Retirement Systems of Alabama increased its position in CVS Health Corporation by 8.7% in the second quarter. Retirement Systems of Alabama now owns 1,043,349 shares of the pharmacy operator’s stock worth $99,890,000 after buying an additional 83,608 shares during the period. Atwood & Palmer Inc. increased its position in shares of CVS Health Corporation by 1.5% in the second quarter. Atwood & Palmer Inc. now owns 202,127 shares of the pharmacy operator’s stock worth $19,352,000 after buying an additional 3,059 shares during the last quarter. TIAA CREF Trust Co. FSB MO increased its position in shares of CVS Health Corporation by 2.5% in the second quarter. TIAA CREF Trust Co. FSB MO now owns 200,005 shares of the pharmacy operator’s stock worth $19,149,000 after buying an additional 4,913 shares during the last quarter. Sentry Investments Corp. increased its position in shares of CVS Health Corporation by 6.3% in the first quarter. Sentry Investments Corp. now owns 2,179,600 shares of the pharmacy operator’s stock worth $226,090,000 after buying an additional 128,300 shares during the last quarter. Finally, Lodestar Investment Counsel LLC IL increased its position in shares of CVS Health Corporation by 4.2% in the second quarter. Lodestar Investment Counsel LLC IL now owns 176,387 shares of the pharmacy operator’s stock worth $16,887,000 after buying an additional 7,136 shares during the last quarter. Institutional investors and hedge funds own 80.95% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) opened at 88.80 on Friday. The stock’s 50 day moving average price is $90.11 and its 200 day moving average price is $96.45. The firm has a market capitalization of $94.68 billion, a price-to-earnings ratio of 20.43 and a beta of 0.83. CVS Health Corporation has a one year low of $85.41 and a one year high of $106.67.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. The business earned $43.70 billion during the quarter, compared to the consensus estimate of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The firm’s revenue was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.19 earnings per share. Analysts expect that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th will be paid a dividend of $0.425 per share. The ex-dividend date is Thursday, October 20th. This represents a $1.70 dividend on an annualized basis and a yield of 1.91%. CVS Health Corporation’s dividend payout ratio (DPR) is currently 39.08%.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.